Tufts researchers find key to treating eye diseases

Fri, 08/20/2010 - 9:33am
Mass High Tech: The Journal of New England Technology

Scientists at Tufts University School of Medicine and the Sackler School of Graduate Biomedical Sciences at Tufts have demonstrated non-viral gene therapy that may delay degenerative eye disorders. The research was conducted in a study to be published in Molecular Therapy.

The gene therapy relies on nanoparticles to protect DNA and prevent retinal cell death, according to Rajendra Kumar-Singh, senior author of the study and associate professor of ophthalmology at the school of medicine. Kumar-Singh also noted that, rather than use nanoparticles, gene therapy typically relies on a virus for DNA delivery, even though the immune response could lead to inflammation, cancer or death.

The research team conducted a gene therapy test on mice, which showed better eyesight seven days after the subjects receiveg treatment.

Read more about the study on the Tufts University website.





Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.